Repository logo
  • English
  • Català
  • Čeština
  • Deutsch
  • Español
  • Français
  • Gàidhlig
  • Italiano
  • Latviešu
  • Magyar
  • Nederlands
  • Polski
  • Português
  • Português do Brasil
  • Suomi
  • Svenska
  • Türkçe
  • Tiếng Việt
  • Қазақ
  • বাংলা
  • हिंदी
  • Ελληνικά
  • Yкраї́нська
  • Sign In
    New user? Click here to register.Have you forgotten your password?
Repository logo
  • Institutions & Repositories
  • Query NERD by:
  • English
  • Català
  • Čeština
  • Deutsch
  • Español
  • Français
  • Gàidhlig
  • Italiano
  • Latviešu
  • Magyar
  • Nederlands
  • Polski
  • Português
  • Português do Brasil
  • Suomi
  • Svenska
  • Türkçe
  • Tiếng Việt
  • Қазақ
  • বাংলা
  • हिंदी
  • Ελληνικά
  • Yкраї́нська
  • Sign In
    New user? Click here to register.Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Akingbade GT"

Now showing 1 - 1 of 1
Results Per Page
Sort Options
  • Loading...
    Thumbnail Image
    Item
    Bioactive component of aqueous extract of Solanum melongena ameliorate estradiol valerate induced ovarian-pituitary dysfunctions in female Sprague–Dawley rats: Histomorphological and biochemical evidence
    (2022) Adelakun SA; Akintunde OW; Akingbade GT; Adedotun OA
    Background Estradiol valerate (EV) is known to cause hypothalamic-pituitary dysregulation of the gonadotrophin-releasing hormone. This study focused on the impact of aqueous extract of Solanum melongena (SM) on EV-induced ovarian-pituitary dysfunction in female Sprague-Dawley rats. Methods Thirty-two healthy female Sprague Dawley rats weighing (8 weeks old; weight 150–200 g) were randomly divided into four groups of eight (n = 8) rats each. Group A received 2 ml of distilled water, Group B received a single dose of 4 mg/kg body weight (bwt) of EV (i.p), Group C received 500 mg/kg bwt SM extract orally and Group D received a single dose of 4 mg/kg bwt of EV (i.p) and 500 mg/kg bwt of SM orally, the experiment lasted for 21days. The following parameters body weight, pituitary gland weight, ovary weight, ovary, and pituitary gland histomorphology, total antioxidant status (TOS), total oxidant status (TOS), oxidative stress index (OSI), total cholesterol (TC), triglyceride, low-density lipoprotein (LDL), and high-density lipoprotein (HDL), progesterone, FSH, LH, Testosterone, and estradiol were assessed. Results Estradiol valerate decreases the number of healthy follicles, progesterone, estradiol, HDL, and TAS. And increase degenerated cystic follicles, TT, FSH, LH, triglyceride, TC, LAL, TOS, and OSI. Pituitary gland showed degenerative changes, characterized by neutrophil infiltrations and loss of cellular projections marked improvement was observed in the ovary, pituitary gland, hormone, and biochemical parameters after SM administration. Conclusion Solanum melongena offers protection against EV-induced ovarian-pituitary dysfunctions evidence by restoration of oxidative stress markers, steroidogenesis, and histopathological alterations back to control level.
THE NERD SYSTEM

Nigeria Education Repository and Databank (NERD) is the official unified digital platform and a one-stop-shop for the national management, administration, and preservation of education data, records, documents and audio-visual assets as a national reference point for education data consistency - supporting the education sector and library services.

QUICK MENU
  • About NERD
  • Contact and Support
  • Other NERD Services
  • Internal/External Examiner Sign up
  • Student/Lecturer's Sign up
  • Regulatory Agencies
ONGOING ACTION
  • Register Your Institution
  • Training
  • Donate Manuscript
  • Donate Parents' Works
  • Investors
  • Annual Prize and Award
  • Thesis & Dissertation
  • Annual Competition
  • Lecturers' Scholarly Article Prizes
  • Essay Prizes
DIGITAL BANK TOOLS
  • Plagiarism Check
  • NCMVS
  • Publish on NERD
  • Peer Review Publications
  • Futile Hypothesis
  • NERD Receipt
  • InfoGraphics

NERD System Copyright © Federal Ministry of Education.

  • Cookie settings  | 
  • Terms and Conditions  |  
  • End Users Agreement  | 
  • Privacy Policy